SynthesisPloS one2022

Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies.

Akhil Sasidharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.